Directori de persones
Joan Valls Marsal

Joan Valls Marsal

Grau: Doctor/a

28 02
joan.valls(ELIMINAR)@udl.cat

Grups

Publicacions

  • Gemeno C; Laserna N; Riba M; Valls J; Castañé C; Alomar O

    Cuticular hydrocarbons discriminate cryptic Macrolophus species (Hemiptera: Miridae)

    Bulletin of Entomological Research 102 624-631. .

    [doi:10.1017/S0007485312000193]

  • Sorolla, Anabel; Yeramian, Andree; Valls, Joan; Dolcet, Xavier; Bergada, Laura; Llombart-Cussac, Antoni; Maria Marti, Rosa; Matias-Guiu, Xavier

    Blockade of NF kappa B activity by Sunitinib increases cell death in Bortezomib-treated endometrial carcinoma cells

    MOLECULAR ONCOLOGY 6 530-541. .

    [doi:10.1016/j.molonc.2012.06.006]

  • Castelblanco, Esmeralda; Gallel, Pilar; Ros, Susana; Gatius, Sonia; Valls, Joan; De-Cubas, Aguirre A.; Maliszewska, Agnieszka; Yebra-Pimentel, M. Teresa; Menarguez, Javier; Gamallo, Carlos; Opocher, Giuseppe; Robledo, Mercedes; Matias-Guiu, Xavier

    Thyroid paraganglioma. Report of 3 cases and description of an immunohistochemical profile useful in the differential diagnosis with medullary thyroid carcinoma, based on complementary DNA array results

    HUMAN PATHOLOGY 43 1103-1112. .

    [doi:10.1016/j.humpath.2011.08.022]

  • Yeramian, Andree; Sorolla, Anabel; Velasco, Ana; Santacana, Maria; Dolcet, Xavier; Valls, Joan; Abal, Leandre; Moreno, Sara; Egido, Ramon; Casanova, Josep M.; Puig, Susana; Vilella, Ramon; Llombart-Cussac, Antonio; Matias-Guiu, Xavier; Marti, Rosa M.

    Inhibition of activated receptor tyrosine kinases by Sunitinib induces growth arrest and sensitizes melanoma cells to Bortezomib by blocking Akt pathway

    INTERNATIONAL JOURNAL OF CANCER 130 967-978. .

    [doi:10.1002/ijc.26096]

  • Pallares, J; Bergada, L; Santacana, M; Dolcet, X; Valls, J; Dusso, A; Matias-Guiu, X

    Downregulation of CYP27A1 Expression and Activity in Human Endometrial Carcinoma Implicates an Abnormal Bioactivation of Vitamin D in Advanced Endometrial Carcinogenesis

    Modern Pathology 25 291-291. .

  • Gatius, Sonia; Velasco, Ana; Azueta, Ainara; Santacana, Maria; Pallares, Judit; Valls, Joan; Dolcet, Xavier; Prat, Jaime; Matias-Guiu, Xavier

    FGFR2 alterations in endometrial carcinoma.

    Modern Pathology 24 1500-1510. .

    [doi:10.1038/modpathol.2011.110]

  • Usie, Anabel; Karathia, Hiren; Teixido, Ivan; Valls, Joan; Faus, Xavier; Alves, Rui; Solsona, Francesc

    Biblio-MetReS: a bibliometric network reconstruction application and server.

    Bmc Bioinformatics 12 387-387. .

    [doi:10.1186/1471-2105-12-387]

  • Velasco, Ana; Pallares, Judit; Santacana, Maria; Gatius, Sonia; Fernandez, Melisa; Domingo, Monica; Valls, Joan; Yeramian, Andree; Encinas, Mario; Dolcet, Xavier; Matias-Guiu, Xavier

    Promoter hypermethylation and expression of sprouty 2 in endometrial carcinoma.

    HUMAN PATHOLOGY 42 185-193. .

    [doi:10.1016/j.humpath.2010.08.001]

  • Valls, Joan; Cleries, Ramon; Galvez, Jordi; Moreno, Victor; Gispert, Rosa; Borras, Josep M.; Ribes, Josepa

    RiskDiff: a web tool for the analysis of the difference due to risk and demographic factors for incidence or mortality data

    BMC PUBLIC HEALTH 9 -. .

    [doi:10.1186/1471-2458-9-473]

  • Cleries, R.; Martinez, J. M.; Valls, J.; Pareja, L.; Esteban, L.; Gispert, R.; Moreno, V.; Ribes, J.; Borras, J. M.

    Life expectancy and age-period-cohort effects: analysis and projections of mortality in Spain between 1977 and 2016.

    Public Health 123 156-162. .

    [doi:10.1016/j.puhe.2008.10.026]

  • Hartmann E; Fernàndez V; Moreno V; Valls J; Hernández L; Bosch F; Abrisqueta P; Klapper W; Dreyling M; Hoster E; Müller-Hermelink HK; Ott G; Rosenwald A; Campo E

    Five-gene model to predict survival in mantle-cell lymphoma using frozen or formalin-fixed, paraffin-embedded tissue.

    Journal of Clinical Oncology 26 4966-4972. .

    [doi:10.1200/JCO.2007.12.0410]

  • Ribes J; Clèries R; Buxó M; Ameijide A; Valls J; Gispert R

    Proyección de la incidencia y la mortalidad del cáncer en Cataluña hasta el año 2015 mediante un modelo bayesiano.

    MEDICINA CLINICA 131 Suppl 1 32-41. .

Projectes

  • Effects of intravenous iron therapy with ferric carboxymaltose compared with oral iron therapy in heart failure with preserved ejection fraction and iron deficency/ Efecto sobre la capacidad funcional del tratamiento con hierro intravenoso o hierro oral, comparado con placebo, en pacientes con insuficiencia cardiaca con fracción de eyección del ventrículo izquierdo preservada y anemia ferropénica
  • Genomic approach for individualizing endometrial cancer diagnosis, prognosis and treatment
  • VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU